Xiamen Kingdomway Group Co operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xiamen Kingdomway Group Co with three other
companies in this sector in China:
Fuan Pharmaceutical Group Co Ltd
sales of 2.09 billion Chinese Renmimbi [US$302.50 million]
of which 100%
was Pharmaceutical Industry),
Tianjin Tianyao Pharmaceutical, Ltd.
(1.97 billion Chinese Renmimbi [US$285.27 million]
PKU HealthCare Corp Ltd
(2.15 billion Chinese Renmimbi [US$310.47 million]
of which 80%
was Merchandise&Material Selling).
Xiamen Kingdomway Group Co reported sales of 2.08 billion Chinese Renmimbi (US$301.60 million)
December of 2017.
increase of 25.4%
versus 2016, when the company's sales were 1.66 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Xiamen Kingdomway Group Co.
Sales of Health saw an increase
25.5% in 2017, from
1.65 billion Chinese Renmimbi to 2.07 billion Chinese Renmimbi.